Lin Wu Selected Research

Neoplasms (Cancer)

5/2024	Cysteine and glycine-rich protein 2 is crucial for maintaining the malignant phenotypes of gliomas through its action on Notch signalling cascade.
3/2024	KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2.
1/2024	Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.
1/2024	Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.
1/2024	Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study.
1/2024	A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer.
1/2024	Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors.
12/2023	Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial.
10/2023	Selpercatinib monotherapy in a Chinese patient with RET fusion/ EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report.
8/2023	A laser free self-luminous nanosystem for photodynamic therapy of cervical cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Wu Research Topics

Disease

124	Neoplasms (Cancer) 05/2024 - 08/2002
70	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2013
23	Inflammation (Inflammations) 04/2023 - 01/2012
21	Disease Progression 05/2024 - 12/2014
21	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2013
18	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2011
18	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2022 - 12/2008
17	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 01/2011
17	Hypertension (High Blood Pressure) 01/2024 - 09/2014
16	Fibrosis (Cirrhosis) 10/2023 - 11/2012
14	Breast Neoplasms (Breast Cancer) 01/2024 - 07/2006
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2019
13	Hypoxia (Hypoxemia) 11/2023 - 01/2011
11	Carcinogenesis 05/2024 - 11/2012
11	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2013
11	Infections 11/2023 - 01/2011
11	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 01/2013
10	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 09/2014
9	Lymphoma (Lymphomas) 02/2023 - 10/2009
9	Heart Failure 01/2023 - 01/2013
9	Acute Kidney Injury (Acute Renal Failure) 12/2022 - 01/2017
8	Adenocarcinoma of Lung 02/2024 - 12/2020
8	Reperfusion Injury 02/2024 - 01/2013
8	Brain Ischemia (Cerebral Ischemia) 04/2022 - 02/2015
8	Ischemia 01/2021 - 04/2008
8	Carcinoma (Carcinomatosis) 01/2021 - 01/2010
8	Ventricular Tachycardia 01/2019 - 01/2004
8	Torsades de Pointes (Torsade de Pointes) 01/2013 - 01/2004
7	Rheumatoid Arthritis 02/2024 - 01/2010
7	Ischemic Stroke 01/2023 - 07/2015
7	Atrial Fibrillation 01/2023 - 01/2004
7	Adenocarcinoma 01/2023 - 04/2014
7	Diabetic Nephropathies (Diabetic Nephropathy) 11/2022 - 01/2014
7	Obesity 04/2022 - 07/2010
6	Brain Neoplasms (Brain Tumor) 04/2024 - 01/2020
6	Hemorrhage 11/2023 - 12/2013
6	Fever (Fevers) 03/2023 - 09/2014
6	Insulin Resistance 11/2022 - 01/2012
6	Chronic Renal Insufficiency 04/2022 - 07/2007
6	Esophageal Squamous Cell Carcinoma 01/2022 - 09/2015
6	Necrosis 12/2021 - 08/2015
6	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2009
6	Proteinuria 10/2020 - 05/2018
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2013 - 11/2012
5	Glioma (Gliomas) 05/2024 - 12/2013
5	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 01/2011
5	Cardiotoxicity 04/2024 - 01/2020
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 12/2002
5	Atherosclerosis 01/2024 - 05/2014
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 01/2018
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2023 - 01/2016
5	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 08/2017
5	Cerebral Infarction 02/2023 - 07/2009
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022 - 01/2010

Drug/Important Bio-Agent (IBA)

54	Proteins (Proteins, Gene)FDA Link 05/2024 - 08/2005
35	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2010
21	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2013
20	Tyrosine Kinase InhibitorsIBA 02/2024 - 04/2013
16	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 07/2009
15	Messenger RNA (mRNA)IBA 01/2023 - 12/2006
14	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2018
12	anlotinibIBA 03/2024 - 11/2018
12	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 07/2006
11	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 09/2014
11	SodiumIBA 07/2023 - 08/2004
11	Indicators and Reagents (Reagents)IBA 01/2023 - 07/2012
10	Therapeutic UsesIBA 11/2022 - 07/2009
10	Rituximab (Mabthera)FDA Link 05/2014 - 11/2011
9	PlatinumIBA 01/2024 - 02/2016
9	MicroRNAs (MicroRNA)IBA 04/2023 - 02/2016
9	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 04/2008
8	CytokinesIBA 01/2024 - 09/2014
8	Complement System Proteins (Complement)IBA 12/2020 - 11/2011
7	NivolumabIBA 05/2024 - 01/2019
7	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2015
7	CholesterolIBA 01/2024 - 01/2005
7	Gefitinib (Iressa)FDA Link 11/2022 - 01/2018
7	Long Noncoding RNAIBA 09/2022 - 12/2015
7	Neuroprotective AgentsIBA 01/2020 - 05/2012
6	Docetaxel (Taxotere)FDA Link 03/2024 - 04/2012
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2015
6	sintilimabIBA 01/2023 - 01/2021
6	CreatinineIBA 11/2022 - 01/2019
6	Phosphotransferases (Kinase)IBA 11/2022 - 05/2013
6	Ranolazine FDA Link 01/2018 - 08/2004
5	6-methyladenineIBA 04/2024 - 09/2015
5	camrelizumabIBA 01/2024 - 01/2021
5	LipidsIBA 12/2023 - 01/2016
5	Amyloid (Amyloid Fibrils)IBA 04/2023 - 10/2017
5	Interleukin-6 (Interleukin 6)IBA 02/2023 - 11/2016
5	LigandsIBA 01/2023 - 07/2014
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2011

Therapy/Procedure

92	Therapeutics 03/2024 - 03/2005
54	Drug Therapy (Chemotherapy) 05/2024 - 01/2004
19	Immunotherapy 01/2024 - 06/2018
7	Photothermal Therapy 02/2024 - 09/2013
6	Radiotherapy 09/2021 - 03/2015
5	Punctures 03/2023 - 02/2008
5	Adjuvant Chemotherapy 01/2023 - 07/2006
5	Length of Stay 11/2022 - 05/2013